Finance

Lists
BMEA:NASDAQ
Biomea Fusion Inc
1,80 USD
+1,12%
(+0,020) 1D
1,80 USD
0,00% (0,00)
Pre-market
Closed: 15-сен., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BMEA...
Open
1,79 USD
High
1,82 USD
Low
1,66 USD
Mkt. cap
130,47 млн
Avg. vol.
1,69 млн
Volume
1,10 миң
52-wk high
2,99 USD
52-wk low
0,87 USD
EPS
-0,50 USD
Beta
-0,23
Shares outstanding
72,48 млн
No. of employees
37
Open
1,79 USD
High
1,82 USD
Low
1,66 USD
Mkt. cap
130,47 млн
Avg. vol.
1,69 млн
Volume
1,10 миң
52-wk high
2,99 USD
52-wk low
0,87 USD
EPS
-0,50 USD
Beta
-0,23
Shares outstanding
72,48 млн
No. of employees
37
News stories
From web sources and news partners
About Biomea Fusion Inc
CEO-
Employees37
Founded2017
HeadquartersСан Карлос, Калифорния, Америка Кошмо Штаттары
Sector-
Websitebiomeafusion.com
Analyst ratings
Based on 5 analysts giving stock ratings to BMEA in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BMEA in the last 3 months.
Highest
Current 1,80 USD
9,00 USD (+400,00%)
Average
6,80 USD (+277,78%)
Lowest
4,00 USD (+122,22%)
Analyst
Recommendation
Action
Price target
Projected
Date
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
4,00 USD
+122,2%
08/24/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
7,00 USD
+288,9%
08/14/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
7,00 USD
+288,9%
08/10/2026
Jonathan Wolleben
Citizens JMP
Buy
Maintained
7,00 USD
+288,9%
08/06/2026
Matthew Biegler
Oppenheimer
Buy
Reiterated
9,00 USD
+400%
08/06/2026
Anupam Rama
J.P. Morgan
Sell
Maintained
-
-
03/24/2026
Last report
2026-ж., 5-авг.
Fiscal period
Q2 2026
EPS / Est. (USD)
-0,12 USD / -0,23 USD
+48,07%beat
Revenue / Est. (USD)
- / 0,00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14,40 млн
8,12 млн
9,12 млн
9,14 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,20 млн
3,60 млн
3,65 млн
3,62 млн
Operating expense
18,60 млн
11,72 млн
12,77 млн
12,77 млн
Total operating expenses
18,60 млн
11,72 млн
12,77 млн
12,77 млн
Operating income
-18,60 млн
-11,72 млн
-12,77 млн
-12,77 млн
Other non operating income
-
19,86 млн
-581,00 миң
4,12 млн
EBT including unusual items
-16,41 млн
4,61 млн
-12,42 млн
-8,33 млн
EBT excluding unusual items
-14,20 млн
4,61 млн
-12,92 млн
-8,33 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-16,41 млн
4,61 млн
-12,42 млн
-8,33 млн
Net profit margin
-
-
-
-
Earnings per share
-0,24
-0,12
-0,17
-0,17
Interest and investment income
4,40 млн
-
430,00 миң
319,00 миң
Interest expense
-
-3,53 млн
-
-
Net interest expenses
4,40 млн
-3,53 млн
430,00 миң
319,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-18,17 млн
-11,67 млн
-12,73 млн
-12,75 млн
Gain or loss from assets sale
-
-
-510,00 миң
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору